The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse
Open accessAbstract
It is believed that mucoadhesive surface properties on particles delivered to the gastrointestinal (GI) tract improve oral absorption or local targeting of various difficult-to-deliver drug classes. To test the effect of nanoparticle mucoadhesion on distribution of nanoparticles in the GI tract, we orally and rectally administered nano- and microparticles that we confirmed possessed surfaces that were either strongly mucoadhesive or non-mucoadhesive. We found that mucoadhesive particles (MAP) aggregated in mucus in the center of the GI lumen, far away from the absorptive epithelium, both in healthy mice and in a mouse model of ulcerative colitis (UC). In striking contrast, water absorption by the GI tract rapidly and uniformly transported non-mucoadhesive mucus-penetrating particles (MPP) to epithelial surfaces, including reaching the surfaces between villi in the small intestine. When using high gavage fluid volumes or injection into ligated intestinal loops, common methods for assessing oral drug and nanoparticle absorption, we found that both MAP and MPP became well-distributed throughout the intestine, indicating that the barrier properties of GI mucus were compromised. In the mouse colorectum, MPP penetrated into mucus in the deeply in-folded surfaces to evenly coat the entire epithelial surface. Moreover, in a mouse model of UC, MPP were transported preferentially into the disrupted, ulcerated tissue. Our results suggest that delivering drugs in non-mucoadhesive MPP is likely to provide enhanced particle distribution, and thus drug delivery, in the GI tract, including to ulcerated tissues.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria
Johansson, M. E. V., Phillipson, M., Petersson, J., Velcich, A., Holm, L., & Hansson, G. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803124105 · Cited by 2,200
Inflammatory bowel disease: Etiology and pathogenesis
Fiocchi, C. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70381-6 · Cited by 2,059
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
Lai, S. K., Wang, Y.-Y., & Hanes, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.11.002 · Cited by 1,815
Self-citationOral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers
Ensign, L. M., Cone, R., & Hanes, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.009 · Cited by 1,623
Self-citationKararli, T. T. (1995) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2510160502 · Cited by 1,459
Cone, R. A. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.008 · Cited by 1,459
Self-citationOral drug absorption enhancement by chitosan and its derivatives
Thanou, M., Verhoef, J. C., & Junginger, H. E. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00231-9 · Cited by 689
Nance, E. A., Woodworth, G. F., Sailor, K. A., Shih, T.-Y., Xu, Q., Swaminathan, G., Xiang, D., Eberhart, C., & Hanes, J. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003594 · Cited by 649
Self-citationSize-Dependent Bioadhesion of Micro- and Nanoparticulate Carriers to the Inflamed Colonic Mucosa
Lamprecht, A., Schäfer, U., & Lehr, C.-M. (2001) · Pharmaceutical Research · doi:10.1023/a:1011032328064 · Cited by 507
Biodegradable Nanoparticles for Targeted Drug Delivery in Treatment of Inflammatory Bowel Disease
Lamprecht, A., Ubrich, N., Yamamoto, H., Schäfer, U., Takeuchi, H., Maincent, P., Kawashima, Y., & Lehr, C.-M. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29290-9 · Cited by 403
Gupta, S., Kesarla, R., & Omri, A. (2013) · ISRN Pharmaceutics · doi:10.1155/2013/848043 · Cited by 380
Behrens, I., Pena, A. I. V., Alonso, M. J., & Kissel, T. (2002) · Pharmaceutical Research · doi:10.1023/a:1019854327540 · Cited by 372
Bacteria Penetrate the Inner Mucus Layer before Inflammation in the Dextran Sulfate Colitis Model
Johansson, M. E. V., Gustafsson, J. K., Sjöberg, K. E., Petersson, J., Holm, L., Sjövall, H., & Hansson, G. C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012238 · Cited by 368 · cited 1×
“In addition to mucus gel hypersecretion, inflammation is associated with breakdown of the adherent mucus layer in the colon, which normally excludes bacteria in the healthy colon [66], leading to bacterial infiltration into the tissue [67, 68].”
BackgroundMucus-Penetrating Nanoparticles for Vaginal Drug Delivery Protect Against Herpes Simplex Virus
Ensign, L. M., Tang, B. C., Wang, Y.-Y., Tse, T. A., Hoen, T., Cone, R., & Hanes, J. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003453 · Cited by 368
Self-citationMarteau, P., Probert, C. S., Lindgren, S., Gassul, M., Tan, T. G., Dignass, A., Befrits, R., Midhagen, G., Rademaker, J., & Foldager, M. (2005) · Gut · doi:10.1136/gut.2004.060103 · Cited by 362
Carino, G. P., & Mathiowitz, E. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00075-1 · Cited by 347
Roger, E., Lagarce, F., Garcion, E., & Benoit, J.-P. (2010) · Nanomedicine · doi:10.2217/nnm.09.110 · Cited by 324
(1995) · Gastroenterology · doi:10.1016/0016-5085(95)27940-7 · Cited by 322
Dawson, M., Wirtz, D., & Hanes, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309026200 · Cited by 316
Self-citationAltered permeability in inflammatory bowel disease: pathophysiology and clinical implications
Mankertz, J., & Schulzke, J.-D. (2007) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32816aa392 · Cited by 312
Schultsz, C., van den Berg, F. M., ten Kate, F. W., Tytgat, G. N. J., & Dankert, J. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70393-8 · Cited by 312
Mucus Penetrating Nanoparticles: Biophysical Tool and Method of Drug and Gene Delivery
Ensign, L. M., Schneider, C., Suk, J. S., Cone, R., & Hanes, J. (2012) · Advanced Materials · doi:10.1002/adma.201201800 · Cited by 290
Self-citationNanoscale technology of mucoadhesive interactions
Peppas, N. A., & Huang, Y. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.03.001 · Cited by 264
Micronization: A method of improving the bioavailability of poorly soluble drugs
Chaumeil, J. C. (1998) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.1998.20.3.485666 · Cited by 242
Schmidt, C., Lautenschlaeger, C., Collnot, E.-M., Schumann, M., Bojarski, C., Schulzke, J.-D., Lehr, C.-M., & Stallmach, A. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.10.019 · Cited by 237
Inflammatory Bowel Disease and the Apical Junctional Complex
BRUEWER, M., SAMARIN, S., & NUSRAT, A. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1326.017 · Cited by 223
Engineering design and molecular dynamics of mucoadhesive drug delivery systems as targeting agents
Serra, L., Doménech, J., & Peppas, N. A. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.022 · Cited by 217
Ulbrich, W., & Lamprecht, A. (2010) · Journal of The Royal Society Interface · doi:10.1098/rsif.2009.0285.focus · Cited by 197
Lung gene therapy with highly compacted DNA nanoparticles that overcome the mucus barrier
Suk, J. S., Kim, A. J., Trehan, K., Schneider, C. S., Cebotaru, L., Woodward, O. M., Boylan, N. J., Boyle, M. P., Lai, S. K., Guggino, W. B., et al. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.01.007 · Cited by 192
Self-citationOral delivery of proteins by biodegradable nanoparticles
Bakhru, S. H., Furtado, S., Morello, A. P., & Mathiowitz, E. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.04.006 · Cited by 190
Lamprecht, A., Yamamoto, H., Takeuchi, H., & Kawashima, Y. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.088146 · Cited by 187
The road map to oral bioavailability: an industrial perspective
Thomas, V. H., Bhattachar, S., Hitchingham, L., Zocharski, P., Naath, M., Surendran, N., Stoner, C. L., & El-Kattan, A. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.4.591 · Cited by 168
Drug delivery to inflamed colon by nanoparticles: Comparison of different strategies
Coco, R., Plapied, L., Pourcelle, V., Jérôme, C., Brayden, D. J., Schneider, Y.-J., & Préat, V. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.07.017 · Cited by 162
Strategies to improve oral drug bioavailability
Gómez-Orellana, I. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.3.419 · Cited by 144
Transport of Polymeric Nanoparticle Gene Carriers in Gastric Mucus
Dawson, M., Krauland, E. M., Wirtz, D., & Hanes, J. S. (2004) · Biotechnology Progress · doi:10.1021/bp0342553 · Cited by 142
Self-citationChen, D., Xia, D., Li, X., Zhu, Q., Yu, H., Zhu, C., & Gan, Y. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.04.002 · Cited by 141
PEG-functionalized microparticles selectively target inflamed mucosa in inflammatory bowel disease
Lautenschläger, C., Schmidt, C., Lehr, C., Fischer, D., & Stallmach, A. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.09.016 · Cited by 139
Makhlof, A., Werle, M., Tozuka, Y., & Takeuchi, H. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.02.001 · Cited by 137
Intestinal solute carriers: an overview of trends and strategies for improving oral drug absorption
Steffansen, B., Nielsen, C. U., Brodin, B., Eriksson, A. H., Andersen, R., & Frøkjær, S. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2003.10.010 · Cited by 132
Cai, Z., Wang, Y., Zhu, L., & Liu, Z. (2010) · Current Drug Metabolism · doi:10.2174/138920010791110836 · Cited by 120
Hunter, A. C., Elsom, J., Wibroe, P. P., & Moghimi, S. M. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.07.005 · Cited by 108
Reineke, J., Cho, D., Dingle, Y. L., Morello, A. P., Jacob, J. S., Thanos, C. G., & Mathiowitz, E. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305882110 · Cited by 106
Hussain, N., & Florence, A. T. (1998) · Pharmaceutical Research · doi:10.1023/a:1011981610840 · Cited by 94
Mucoadhesive intestinal devices for oral delivery of salmon calcitonin
Gupta, V., Hwang, B. H., Lee, J. H., Anselmo, A. C., Doshi, N., & Mitragotri, S. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.09.004 · Cited by 89
Bioadhesive properties of pegylated nanoparticles
Yoncheva, K., Gómez, S., Campanero, M. Á., Gamazo, C., & Irache, J. M. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.2.205 · Cited by 81
Kulvanich, P., Sinsuebpol, C., & Chatchawalsaisin, J. (2013) · Drug Design Development and Therapy · doi:10.2147/dddt.s47681 · Cited by 77
Enhanced vaginal drug delivery through the use of hypotonic formulations that induce fluid uptake
Ensign, L. M., Hoen, T. E., Maisel, K., Cone, R. A., & Hanes, J. S. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.05.039 · Cited by 69
Self-citationExtracellular matrix protein lumican regulates inflammation in a mouse model of colitis
Lohr, K., Sardana, H., Lee, S., Wu, F., Huso, D. L., Hamad, A. R. A., & Chakravarti, S. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21713 · Cited by 67
Uskoković, V., Lee, P. P., Walsh, L. A., Fischer, K. E., & Desai, T. A. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.010 · Cited by 64
Intestinal Patches for Oral Drug Delivery
Shen, Z., & Mitragotri, S. (2002) · Pharmaceutical Research · doi:10.1023/a:1015118923204 · Cited by 63
Kim, A. J., Boylan, N. J., Suk, J. S., Hwangbo, M., Yu, T., Schuster, B. S., Cebotaru, L., Lesniak, W. G., Oh, J. S., Adstamongkonkul, P., et al. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201208556 · Cited by 62
Self-citationEyles, J. E., Alpar, H. O., Field, W. N., Lewis, D., & Keswick, M. (1995) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1995.tb06714.x · Cited by 61
Targeting Receptors, Transporters and Site of Absorption to Improve Oral Drug Delivery
Hamman, J. H., Demana, P. H., & Olivier, E. I. (2007) · Drug Target Insights · doi:10.1177/117739280700200003 · Cited by 56
Oral delivery of insulin loaded poly(fumaric-co-sebacic) anhydride microspheres
Furtado, S., Abramson, D., Burrill, R., Olivier, G. K., Gourd, C. M., Bubbers, E. J., & Mathiowitz, E. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.06.039 · Cited by 55
Durán‐Lobato, M., Muñoz-Rubio, I., Holgado, M. A., Álvarez‐Fuentes, J., Arévalo, M. F., & Martín‐Banderas, L. (2013) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2014.1806 · Cited by 53
Yazbeck, R., Howarth, G. S., Butler, R. N., Geier, M. S., & Abbott, C. A. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22682 · Cited by 51
Leyva, F. J., Bakshi, R. P., Fuchs, E. J., Li, L., Caffo, B. S., Goldsmith, A. J., Ventuneac, A., Carballo‐Diéguez, A., Du, Y., Leal, J. P., et al. (2013) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2013.0189 · Cited by 49
Targeting receptors, transporters and site of absorption to improve oral drug delivery.
Hamman, J. H., Demana, P. H., & Olivier, E. I. (2007) · Europe PMC (PubMed Central) · Cited by 42
Improved Bioavailability of a Micronized Megestrol Acetate Tablet Formulation in Humans
Farinha, A., Bica, A., & Tavares, P. (2000) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-100101270 · Cited by 35
Topical Therapies in Inflammatory Bowel Disease
Frei, P., Biedermann, L., Manser, C. N., Wilk, M. B., Manz, M., Vavricka, S. R., & Rogler, G. (2012) · Digestion · doi:10.1159/000341947 · Cited by 32
Real-Time Multiple Particle Tracking of Gene Nanocarriers in Complex Biological Environments
Lai, S. K., & Hanes, J. S. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-248-3_6 · Cited by 26
Self-citationPeppas, N. A. (1998) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856298x00028 · Cited by 22
Mucoadhesive and Enzymatic Inhibitory Nanoparticles for Transnasal Insulin Delivery
Wang, Y., Zhang, X., Cheng, C., & Li, C. (2014) · Nanomedicine · doi:10.2217/nnm.13.102 · Cited by 20
Absorption of Calcitonin in Oral and Pulmonary Administration with Polymer-coated Liposomes
Takeuchi, H., & Sugihara, H. (2010) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.130.1135 · Cited by 17
Momoh, M. A., Kenechukwu, F. C., Nnamani, P. O., & Umetiti, J. C. (2014) · Drug Delivery · doi:10.3109/10717544.2014.898108 · Cited by 15
Li, J., Chen, C., Cao, X., Wang, G.-H., Jun-bo, H., & Wang, J. (2014) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-014-1232-1 · Cited by 9
Cited by
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523
Self-citationRecent progress in drug delivery
Li, C., Wang, J., Wang, Y., Gao, H., Wei, G., Huang, Y., Yu, H., Gan, Y., Wang, Y., Mei, L., et al. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.08.003 · Cited by 818
Synthetic Nanoparticles for Vaccines and Immunotherapy
Irvine, D. J., Hanson, M. C., Rakhra, K., & Tokatlian, T. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00109 · Cited by 763
Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects
Scioli Montoto, S., Muraca, G., & Ruiz, M. E. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.587997 · Cited by 652
Nanoparticles for oral delivery: Design, evaluation and state-of-the-art
Date, A. A., Hanes, J., & Ensign, L. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.016 · Cited by 539
Self-citation
Metadata
- Authors
- Maisel, K., Ensign, L., Reddy, M., Cone, R., & Hanes, J.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 197
- Pages
- 48-57
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2094577650
- Cited by
- 319
- References
- 66
- FWCI
- 12.03
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.